Anpario Plc Total Liabilities
Anpario Plc total liabilities. Based on the latest financial reports, Anpario Plc (ANP) has total liabilities worth GBX9.53 Million GBX (≈ $1.16K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Anpario Plc to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Anpario Plc (2000–2025)
Total liabilities of Anpario Plc from 2000 to 2025. This chart illustrates how Anpario Plc's total liabilities have evolved over time, based on quarterly financial data.
Anpario Plc Competitors by Total Liabilities
The table below lists competitors of Anpario Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PHAXIAM Therapeutics S.A.
PA:PHXM
|
France | €23.66 Million |
|
BioNeutra Global Corp
V:BGA
|
Canada | CA$21.81 Million |
|
Antarctica Limited
NSE:ANTGRAPHIC
|
India | Rs374.55 Million |
|
Alligator Bioscience AB
ST:ATORX
|
Sweden | Skr61.79 Million |
|
Quintegra Solutions Limited
NSE:QUINTEGRA
|
India | Rs142.76 Million |
|
Fram Skandinavien AB Series B
ST:FRAM-B
|
Sweden | Skr19.35 Million |
|
Sarawak Cable Bhd
KLSE:5170
|
Malaysia | RM466.66 Million |
|
4BASEBIO UK SOCIETAS
LSE:4BB
|
UK | GBX19.44 Million |
Liability Composition Analysis (2000–2025)
This chart breaks down Anpario Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Anpario Plc assets under control.
Liquidity & Leverage Metrics
Anpario Plc Total Liabilities Ratios Explained
Anpario Plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.50 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anpario Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anpario Plc (2000–2025)
The table below shows the annual total liabilities of Anpario Plc from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX9.53 Million ≈ $1.16K |
-12.20% |
| 2024-12-31 | GBX10.85 Million ≈ $1.32K |
+65.81% |
| 2023-12-31 | GBX6.54 Million ≈ $796.34 |
-9.37% |
| 2022-12-31 | GBX7.22 Million ≈ $878.71 |
-5.99% |
| 2021-12-31 | GBX7.68 Million ≈ $934.68 |
+10.15% |
| 2020-12-31 | GBX6.97 Million ≈ $848.53 |
+43.32% |
| 2019-12-31 | GBX4.87 Million ≈ $592.05 |
-3.62% |
| 2018-12-31 | GBX5.05 Million ≈ $614.32 |
-24.40% |
| 2017-12-31 | GBX6.68 Million ≈ $812.64 |
+21.19% |
| 2016-12-31 | GBX5.51 Million ≈ $670.53 |
+12.42% |
| 2015-12-31 | GBX4.90 Million ≈ $596.43 |
-22.41% |
| 2014-12-31 | GBX6.32 Million ≈ $768.72 |
+5.21% |
| 2013-12-31 | GBX6.00 Million ≈ $730.63 |
-7.93% |
| 2012-12-31 | GBX6.52 Million ≈ $793.54 |
+55.25% |
| 2011-12-31 | GBX4.20 Million ≈ $511.14 |
-18.30% |
| 2010-12-31 | GBX5.14 Million ≈ $625.63 |
+1.88% |
| 2009-12-31 | GBX5.05 Million ≈ $614.07 |
+344.67% |
| 2008-12-31 | GBX1.14 Million ≈ $138.10 |
-37.57% |
| 2007-12-31 | GBX1.82 Million ≈ $221.20 |
+5.88% |
| 2006-12-31 | GBX1.72 Million ≈ $208.91 |
+1076.03% |
| 2005-12-31 | GBX146.00K ≈ $17.76 |
-39.67% |
| 2004-12-31 | GBX242.00K ≈ $29.44 |
-51.60% |
| 2003-12-31 | GBX500.00K ≈ $60.84 |
-18.57% |
| 2002-12-31 | GBX614.00K ≈ $74.71 |
+37.98% |
| 2001-12-31 | GBX445.00K ≈ $54.14 |
+22.93% |
| 2000-12-31 | GBX362.00K ≈ $44.04 |
-- |
About Anpario Plc
Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and fee… Read more